title: Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: prediction of clinical status--is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?
authors.forename: C
authors.initials: C
authors.lastname: Hengstenberg
authors.forename: J
authors.initials: J
authors.lastname: Erdmann
authors.forename: P
authors.initials: P
authors.lastname: Charron
mesh_terms: D024741:Cardiomyopathy, Hypertrophic, Familial / Q000175:diagnosis* / Q000235:genetics; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D009154:Mutation; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods; D011379:Prognosis; D024723:Ventricular Myosins / Q000235:genetics*
chemical_list: D024723:Ventricular Myosins